Leucocyte recruitment in inflammation and novel endogenous negative regulators thereof

European Journal of Clinical Investigation

Volumn 42, Issue 6, 2012, Pages 686-691

  Chavakis, Triantafyllos ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Inflammation; Integrin; Leukocyte adhesion; Leukocyte endothelial interactions

Indexed keywords

BETA2 INTEGRIN; CHEMOKINE; CHEMOKINE RECEPTOR; DEVELOPMENTAL ENDOTHELIAL LOCUS 1 PROTEIN; GLYCOPROTEIN; GROWTH DIFFERENTIATION FACTOR 15; IMMUNOGLOBULIN; INTEGRIN; LEUKOCYTE MIGRATION INHIBITION FACTOR; PENTRAXIN 3; SELECTIN; UNCLASSIFIED DRUG;

CELL INFILTRATION; ENDOTHELIUM; IMMUNE SYSTEM; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LEUKOCYTE MIGRATION INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

CELL ADHESION; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; INTEGRINS; LEUKOCYTES; MEMBRANE GLYCOPROTEINS;

EID: 84860892863     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2012.02677.x     Document Type: Review

References (78)

1. Chavakis E, Choi EY, Chavakis T. Novel aspects in the regulation of the leukocyte adhesion cascade. Thromb Haemost 2009;102:191-7.
2. Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 2005;6:1182-90.
3. Langer HF, Chavakis T. Leukocyte-endothelial interactions in inflammation. J Cell Mol Med 2009;13:1211-20.
4. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007;7:678-89.
5. Vestweber D. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol Rev 2007;218:178-96.
6. McEver RP. Selectins: lectins that initiate cell adhesion under flow. Curr Opin Cell Biol 2002;14:581-6.
7. Kinashi T. Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol 2005;5:546-59.
8. Shamri R, Grabovsky V, Gauguet JM, Feigelson S, Manevich E, Kolanus W et al. Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat Immunol 2005;6:497-506.
9. Hyduk SJ, Chan JR, Duffy ST, Chen M, Peterson MD, Waddell TK et al. Phospholipase C, calcium, and calmodulin are critical for alpha4beta1 integrin affinity up-regulation and monocyte arrest triggered by chemoattractants. Blood 2007;109:176-84.
10. Lafuente E, Boussiotis VA. Rap1 regulation of RIAM and cell adhesion. Methods Enzymol 2006;407:345-58.
11. Fagerholm SC, Hilden TJ, Nurmi SM, Gahmberg CG. Specific integrin alpha and beta chain phosphorylations regulate LFA-1 activation through affinity-dependent and -independent mechanisms. J Cell Biol 2005;171:705-15.
12. Choi EY, Orlova VV, Fagerholm SC, Nurmi SM, Zhang L, Ballantyne CM et al. Regulation of LFA-1-dependent inflammatory cell recruitment by Cbl-b and 14-3-3 proteins. Blood 2008;111:3607-14.
13. Han J, Lim CJ, Watanabe N, Soriani A, Ratnikov B, Calderwood DA et al. Reconstructing and deconstructing agonist-induced activation of integrin alphaIIbbeta3. Curr Biol 2006;16:1796-806.
14. Lee HS, Lim CJ, Puzon-McLaughlin W, Shattil SJ, Ginsberg MH. RIAM activates integrins by linking talin to ras GTPase membrane-targeting sequences. J Biol Chem 2009;284:5119-27.
15. Moser M, Bauer M, Schmid S, Ruppert R, Schmidt S, Sixt M et al. Kindlin-3 is required for beta2 integrin-mediated leukocyte adhesion to endothelial cells. Nat Med 2009;15:300-5.
16. Zarbock A, Lowell CA, Ley K. Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1. Immunity 2007;26:773-83.
17. Zarbock A, Abram CL, Hundt M, Altman A, Lowell CA, Ley K. PSGL-1 engagement by E-selectin signals through Src kinase Fgr and ITAM adapters DAP12 and FcR gamma to induce slow leukocyte rolling. J Exp Med 2008;205:2339-47.
18. Salas A, Shimaoka M, Kogan AN, Harwood C, von Andrian UH, Springer TA. Rolling adhesion through an extended conformation of integrin alphaLbeta2 and relation to alpha I and beta I-like domain interaction. Immunity 2004;20:393-406.
19. Hyun YM, Lefort CT, Kim M. Leukocyte integrins and their ligand interactions. Immunol Res 2009;45:195-208.
20. Yonekawa K, Harlan JM. Targeting leukocyte integrins in human diseases. J Leukoc Biol 2005;77:129-40.
21. Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, Linn T et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 2003;198:1507-15.
22. Gahmberg CG, Tian L, Ning L, Nyman-Huttunen H. ICAM-5--a novel two-facetted adhesion molecule in the mammalian brain. Immunol Lett 2008;117:131-5.
23. Gahmberg CG, Valmu L, Fagerholm S, Kotovuori P, Ihanus E, Tian L et al. Leukocyte integrins and inflammation. Cell Mol Life Sci 1998;54:549-55.
24. Springer TA, Thompson WS, Miller LJ, Schmalstieg FC, Anderson DC. Inherited deficiency of the Mac-1, LFA-1, p150, 95 glycoprotein family and its molecular basis. J Exp Med 1984;160:1901-18.
25. Berlin-Rufenach C, Otto F, Mathies M, Westermann J, Owen MJ, Hamann A et al. Lymphocyte migration in lymphocyte function-associated antigen (LFA)-1-deficient mice. J Exp Med 1999;189:1467-78.
26. Prince JE, Brayton CF, Fossett MC, Durand JA, Kaplan SL, Smith CW et al. The differential roles of LFA-1 and Mac-1 in host defense against systemic infection with Streptococcus pneumoniae. J Immunol 2001;166:7362-9.
27. Lee SH, Prince JE, Rais M, Kheradmand F, Ballantyne CM, Weitz-Schmidt G et al. Developmental control of integrin expression regulates Th2 effector homing. J Immunol 2008;180:4656-67.
28. Watts GM, Beurskens FJ, Martin-Padura I, Ballantyne CM, Klickstein LB, Brenner MB et al. Manifestations of inflammatory arthritis are critically dependent on LFA-1. J Immunol 2005;174:3668-75.
29. Lebwohl M, Tyring SK, Hamilton TK, Toth D, Glazer S, Tawfik NH et al. A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N Engl J Med 2003;349:2004-13.
30. Ke Y, Sun D, Zhang P, Jiang G, Kaplan HJ, Shao H. Suppression of established experimental autoimmune uveitis by anti-LFA-1alpha Ab. Invest Ophthalmol Vis Sci 2007;48:2667-75.
31. Xie C, Alcaide P, Geisbrecht BV, Schneider D, Herrmann M, Preissner KT et al. Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus. J Exp Med 2006;203:985-94.
32. Bullard DC, Hu X, Schoeb TR, Axtell RC, Raman C, Barnum SR. Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis. J Immunol 2005;175:6327-33.
33. Ransohoff RM. Natalizumab for multiple sclerosis. N Engl J Med 2007;356:2622-9.
34. Gakidis MA, Cullere X, Olson T, Wilsbacher JL, Zhang B, Moores SL et al. Vav GEFs are required for beta2 integrin-dependent functions of neutrophils. J Cell Biol 2004;166:273-82.
35. Giagulli C, Ottoboni L, Caveggion E, Rossi B, Lowell C, Constantin G et al. The Src family kinases Hck and Fgr are dispensable for inside-out, chemoattractant-induced signaling regulating beta 2 integrin affinity and valency in neutrophils, but are required for beta 2 integrin-mediated outside-in signaling involved in sustained adhesion. J Immunol 2006;177:604-11.
36. Zhang H, Schaff UY, Green CE, Chen H, Sarantos MR, Hu Y et al. Impaired integrin-dependent function in Wiskott-Aldrich syndrome protein-deficient murine and human neutrophils. Immunity 2006;25:285-95.
37. Phillipson M, Heit B, Colarusso P, Liu L, Ballantyne CM, Kubes P. Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade. J Exp Med 2006;203:2569-75.
38. Schenkel AR, Mamdouh Z, Muller WA. Locomotion of monocytes on endothelium is a critical step during extravasation. Nat Immunol 2004;5:393-400.
39. Nourshargh S, Marelli-Berg FM. Transmigration through venular walls: a key regulator of leukocyte phenotype and function. Trends Immunol 2005;26:157-65.
40. Woodfin A, Voisin MB, Beyrau M, Colom B, Caille D, Diapouli FM et al. The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. Nat Immunol 2011;12:761-9.
41. Huang MT, Larbi KY, Scheiermann C, Woodfin A, Gerwin N, Haskard DO et al. ICAM-2 mediates neutrophil transmigration in vivo: evidence for stimulus specificity and a role in PECAM-1-independent transmigration. Blood 2006;107:4721-7.
42. Shaw SK, Ma S, Kim MB, Rao RM, Hartman CU, Froio RM et al. Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigration. J Exp Med 2004;200:1571-80.
43. Mamdouh Z, Chen X, Pierini LM, Maxfield FR, Muller WA. Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis. Nature 2003;421:748-53.
44. Sachs UJ, Andrei-Selmer CL, Maniar A, Weiss T, Paddock C, Orlova VV et al. The neutrophil-specific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31). J Biol Chem 2007;282:23603-12.
45. Bixel MG, Li H, Petri B, Khandoga AG, Khandoga A, Zarbock A et al. CD99 and CD99L2 act at the same site as, but independently of PECAM-1 during leukocyte diapedesis. Blood 2010;116:1172-84.
46. Santoso S, Sachs UJ, Kroll H, Linder M, Ruf A, Preissner KT et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med 2002;196:679-91.
47. Ostermann G, Weber KS, Zernecke A, Schroder A, Weber C. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 2002;3:151-8.
48. Keiper T, Santoso S, Nawroth PP, Orlova V, Chavakis T. The role of junctional adhesion molecules in cell-cell interactions. Histol Histopathol 2005;20:197-203.
49. Orlova VV, Chavakis T. Regulation of vascular endothelial permeability by junctional adhesion molecules (JAM). Thromb Haemost 2007;98:327-32.
50. Corada M, Chimenti S, Cera MR, Vinci M, Salio M, Fiordaliso F et al. Junctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia-reperfusion injury. Proc Natl Acad Sci U S A 2005;102:10634-9.
51. Chavakis T, Keiper T, Matz-Westphal R, Hersemeyer K, Sachs UJ, Nawroth PP et al. The junctional adhesion molecule-C promotes neutrophil transendothelial migration in vitro and in vivo. J Biol Chem 2004;279:55602-8.
52. Aurrand-Lions M, Lamagna C, Dangerfield JP, Wang S, Herrera P, Nourshargh S et al. Junctional adhesion molecule-C regulates the early influx of leukocytes into tissues during inflammation. J Immunol 2005;174:6406-15.
53. Langer HF, Orlova VV, Xie C, Kaul S, Schneider D, Lonsdorf AS et al. A novel function of Junctional Adhesion Molecule-C in mediating melanoma cell metastasis. Cancer Res 2011;71:4096-105.
54. Gotsch U, Borges E, Bosse R, Boggemeyer E, Simon M, Mossmann H et al. VE-cadherin antibody accelerates neutrophil recruitment in vivo. J Cell Sci 1997;5:583-8.
55. Schulte D, Kuppers V, Dartsch N, Broermann A, Li H, Zarbock A et al. Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J 2011;30:4157-70.
56. Orlova VV, Economopoulou M, Lupu F, Santoso S, Chavakis T. Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts. J Exp Med 2006;203:2703-14.
57. Wegmann F, Petri B, Khandoga AG, Moser C, Khandoga A, Volkery S et al. ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability. J Exp Med 2006;203:1671-7.
58. Rhee JS, Santoso S, Herrmann M, Bierhaus A, Kanse SM, May AE et al. New aspects of integrin-mediated leukocyte adhesion in inflammation: regulation by haemostatic factors and bacterial products. Curr Mol Med 2003;3:387-92.
59. Chavakis T, Preissner KT, Herrmann M. The anti-inflammatory activities of Staphylococcus aureus. Trends Immunol 2007;28:408-18.
60. Chavakis T, Hussain M, Kanse SM, Peters G, Bretzel RG, Flock JI et al. Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nat Med 2002;8:687-93.
61. Athanasopoulos AN, Economopoulou M, Orlova VV, Sobke A, Schneider D, Weber H et al. The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms. Blood 2006;107:2720-7.
62. Moyle M, Foster DL, McGrath DE, Brown SM, Laroche Y, De Meutter J et al. A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18. J Biol Chem 1994;269:10008-15.
63. Zhou MY, Lo SK, Bergenfeldt M, Tiruppathi C, Jaffe A, Xu N et al. In vivo expression of neutrophil inhibitory factor via gene transfer prevents lipopolysaccharide-induced lung neutrophil infiltration and injury by a beta2 integrin-dependent mechanism. J Clin Invest 1998;101:2427-37.
64. Rozdzinski E, Sandros J, van der Flier M, Young A, Spellerberg B, Bhattacharyya C et al. Inhibition of leukocyte-endothelial cell interactions and inflammation by peptides from a bacterial adhesin which mimic coagulation factor X. J Clin Invest 1995;95:1078-85.
65. Choi EY, Chavakis E, Czabanka MA, Langer HF, Fraemohs L, Economopoulou M et al. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 2008;322:1101-4.
66. Raymond A, Ensslin MA, Shur BD. SED1/MFG-E8: a bi-motif protein that orchestrates diverse cellular interactions. J Cell Biochem 2009;106:957-66.
67. Hidai C, Zupancic T, Penta K, Mikhail A, Kawana M, Quertermous EE et al. Cloning and characterization of developmental endothelial locus-1: an embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor. Genes Dev 1998;12:21-33.
68. Dasgupta SK, Le A, Chavakis T, Rumbaut RE, Thiagarajan P. Developmental Endothelial Locus-1 (Del-1) Mediates Clearance of Platelet Microparticles by the Endothelium. Circulation 2012; doi:
69. Ho HK, Jang JJ, Kaji S, Spektor G, Fong A, Yang P et al. Developmental endothelial locus-1 (Del-1), a novel angiogenic protein: its role in ischemia. Circulation 2004;109:1314-9.
70. Hidai C, Kawana M, Kitano H, Kokubun S. Discoidin domain of Del1 protein contributes to its deposition in the extracellular matrix. Cell Tissue Res 2007;330:83-95.
71. Eskan MA, Jotwani R, Abe T, Chmelar J, Lim JH, Liang S et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat Immunol 2012;13:465-73.
72. Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005;23:337-66.
73. Cotena A, Maina V, Sironi M, Bottazzi B, Jeannin P, Vecchi A et al. Complement dependent amplification of the innate response to a cognate microbial ligand by the long pentraxin PTX3. J Immunol 2007;179:6311-7.
74. Bottazzi B, Garlanda C, Cotena A, Moalli F, Jaillon S, Deban L et al. The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity. Immunol Rev 2009;227:9-18.
75. Deban L, Russo RC, Sironi M, Moalli F, Scanziani M, Zambelli V et al. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol 2010;11:328-34.
76. Salio M, Chimenti S, De Angelis N, Molla F, Maina V, Nebuloni M et al. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2008;117:1055-64.
77. Kempf T, Zarbock A, Widera C, Butz S, Stadtmann A, Rossaint J et al. GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat Med 2011;17:581-8.
78. Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 2006;98:351-60.